Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
- 1 February 2017
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 49 (2) , 239-242
Abstract
No abstract availableKeywords
Funding Information
- German Center for Infection Research (DZIF)
This publication has 19 references indexed in Scilit:
- Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factorsJournal of Antimicrobial Chemotherapy, 2016
- Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German CommunityAntimicrobial Agents and Chemotherapy, 2014
- Tackling antibiotic resistanceNature Reviews Microbiology, 2011
- Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Evaluation of the Merlin MICRONAUT System for Rapid Direct Susceptibility Testing of Gram-Positive Cocci and Gram-Negative Bacilli from Positive Blood CulturesJournal of Clinical Microbiology, 2007
- Outcome of cephalosporin treatment of bacteremia due to CTX-M–type extended-spectrum β-lactamase–producing Escherichia coliDiagnostic Microbiology and Infectious Disease, 2006
- Plasmid-Determined AmpC-Type β-LactamasesAntimicrobial Agents and Chemotherapy, 2002
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995